Observational Study of ASCVD Risks of Type 2 Diabetes in East China
NCT04866667 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 316
Last updated 2026-04-13
Summary
The aim of this study is to screen patients with type 2 diabetes with high risk of cardiovascular disease, and intervene with or without Glucagon like peptide-1 receptor agonists.
Conditions
- Type 2 Diabetes Mellitus
- Arteriosclerotic Cardiovascular Disease
- Liraglutide
Sponsors & Collaborators
-
Jinhua Hospital of TCM
collaborator UNKNOWN -
Shaoxing Central Hospital
collaborator OTHER -
Shaoxinig Second Hospital
collaborator UNKNOWN -
Zhejiang Provence Preventive Medicine Association
collaborator UNKNOWN -
Ningbo Medical Center Lihuili Hospital
collaborator OTHER_GOV -
Affiliated Cixi Hospital of Wenzhou Medical University
collaborator OTHER -
Putuo People's Hospital
collaborator UNKNOWN -
The Second People's Hospital of Yuhuan
collaborator UNKNOWN -
Affiliated Wenling Hospital of Wenzhou Medical University
collaborator OTHER -
ShuGuang Hospital
collaborator OTHER -
Affiliated Hospital of Jiaxing University
collaborator OTHER -
Nanxun People's Hospital
collaborator UNKNOWN -
The First People's Hospital of Huzhou
collaborator OTHER -
Lishui Hospital of TCM
collaborator UNKNOWN -
Hangzhou hospital of Chinese Traditional Medicine
collaborator UNKNOWN -
Zhejiang Greentown Cardiovascular Hospital
collaborator OTHER -
Red Cross Hospital, Hangzhou, China
collaborator OTHER -
The Second School of Medicine，WMU
collaborator UNKNOWN -
The First People's Hospital of Xiaoshan
collaborator UNKNOWN -
Zhejiang Hospital
collaborator OTHER -
Yiwu Central Hospital
collaborator OTHER -
Quzhou Hospital
collaborator UNKNOWN -
Huamei hospital, University of Chinese Academy of Sciences
collaborator UNKNOWN -
Zhejiang Provincial People's Hospital
lead OTHER
Principal Investigators
-
Xiaohong Wu, MD · Department of Endocriology, Zhejiang Provincial People's Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-01
- Primary Completion
- 2023-12-31
- Completion
- 2024-05-31
Countries
- China
Study Locations
More Related Trials
-
Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus
NCT03707171 ·Status: COMPLETED ·Phase: PHASE3
-
Diabetes Complications and the Risk of Cardiovascular and Cerebrovascular Diseases
NCT04983277 ·Status: NOT_YET_RECRUITING
-
Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China
NCT03064841 ·Status: COMPLETED
-
Clinical Observation of Coronary Arterial Microcirculation Dysfunction in Diabetic Patients With Non- Obstructive Coronary Artery Disease
NCT02748980 ·Status: UNKNOWN
-
Early Identification of Heart Failure in a High-Risk Diabetic Cohort
NCT05866380 ·Status: ACTIVE_NOT_RECRUITING
-
DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan
NCT02226822 ·Status: COMPLETED
-
Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes
NCT03558867 ·Status: COMPLETED ·Phase: NA
-
Xinqiao High-risk Cohort of Diabetes(NICE)
NCT07281170 ·Status: RECRUITING
-
Precision Medicine of Diabetes Program in China
NCT06320600 ·Status: RECRUITING
-
HbA1c Prediction Model in Patients With Type 2 Diabetes
NCT05824286 ·Status: UNKNOWN ·Phase: NA
-
Korea National Diabetes Program
NCT01212198 ·Status: UNKNOWN
-
Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
NCT03132129 ·Status: RECRUITING
-
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
NCT05313529 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Survey on the Treatment of Hypertension in Patients With Type 2 Diabetes
NCT00803660 ·Status: COMPLETED
-
Retinol-binding Protein 4 (RBP4) Metabolizm in Type 2 Diabetes Progression and Associated Cardiovascular Complications
NCT04325126 ·Status: UNKNOWN
-
The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy
NCT06843304 ·Status: RECRUITING
-
Incretin Based Therapy for Poorly Controlled Type 2 Diabetic Patients
NCT02026024 ·Status: COMPLETED
-
Instrument Development of Screening Prediabetes Patients
NCT00308646 ·Status: TERMINATED
-
Correlation Between Targeted HbA1c Values and Prevention of Recurrent Cardiovascular Events in Type 2 Diabetes After PCI
NCT05134129 ·Status: UNKNOWN
-
A Study of Blood Metabolic Markers in Patients With Type 2 Diabetes Mellitus of Different Stages
NCT06155539 ·Status: NOT_YET_RECRUITING
-
China Diabetes Registry by Metabolic Management Center
NCT03811470 ·Status: RECRUITING
-
Assessment of Metabolic Profiles of Lower Extremity Arterial Disease in Patiens Withe Type 2 Diabetes
NCT05068895 ·Status: UNKNOWN
-
Risk Factors of Incidence of Type 2 Diabetes and Cardiovascular Diseases---Shanghai Baoshan Study
NCT00949416 ·Status: UNKNOWN
-
Coronary Artery Calcium-guided Primary Prevention of Major Coronary Heart Disease in Asymptomatic Diabetes
NCT05267990 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Comprehensive Awareness and Control in Diabetes Patients in China Jiangxi: A Cross-Sectional Survey
NCT03363360 ·Status: UNKNOWN